EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies

Go back to EyeGate Pharmaceuticals Completes Enrollment in Both PRK and PE Pilot Studies
(NASDAQ: EYEG) Delayed: 34.52 -0.13 (0.38%)
Previous Close $34.65    52 Week High $5.09 
Open $34.53    52 Week Low $1.11 
Day High $34.54    P/E N/A 
Day Low $34.52    EPS $0.00 
Volume 2,108